PHT releases first ePRO smartphone application

NewsGuard 100/100 Score

PHT Corporation, the global ePRO System innovator, continues to maximize high quality data monitoring for clinical trials with the release of the industry's first ePRO smartphone application. SmartReports Mobile grants site monitors instant access to every clinical trial site and subject compliance data, and compares that data against compliance protocols. The app is free within StudyWorks®, PHT's online clinical patient data reporting system.

One sponsor said, "This app brings mobile convenience to clinical trial compliance monitoring. SmartReports Mobile lets monitors stay completely updated and enables them to drill down on patient compliance and safety anywhere - airport, hotel lobbies, between meetings, wherever - without even opening a laptop!"

Monitors can check that sites and subjects are within compliance rates specified by the protocol and can quickly locate subjects who need follow-up. One tap immediately calls the site to expedite any issues. Many sponsors report that clinical trial sites which frequently check compliance reports often have higher compliance rates. SmartReports Mobile users also can tap on the site to activate the GPS capability of the smartphone to locate the site quickly.

PHT President and CEO Philip Lee said, "We continue to focus on developing new technologies that support our ePRO clients' goals to save time, improve data accessibility and increase compliance in their trials. SmartReports Mobile goes a long way towards strengthening compliance without a lot of overhead - a real game-changer for the ePRO industry."

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Innovative CAR T cell therapy targets two proteins to combat aggressive brain tumor growth